Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 470-710-7 | CAS number: 139122-17-1
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- repeated dose toxicity: oral
- Adequacy of study:
- other information
Data source
Reference
- Reference Type:
- other: Body responsible for the test
- Title:
- Unnamed
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: Annex V
- GLP compliance:
- yes
- Limit test:
- no
Test animals
- Species:
- other: Rat(Sprague-Dawley)
Administration / exposure
- Route of administration:
- oral: unspecified
- Vehicle:
- other: Polyethylene glycol 400.
- Details on oral exposure:
- Method of administration:
Gavage. - Duration of treatment / exposure:
- Test duration: 28 days
- Frequency of treatment:
- Dosing regime: 7 days/week
- No. of animals per sex per dose:
- Male: 5 animals at 150 mg/kg bw/day
Male: 5 animals at 400 mg/kg bw/day
Male: 5 animals at 1000 mg/kg bw/day
Female: 5 animals at 150 mg/kg bw/day
Female: 5 animals at 400 mg/kg bw/day
Female: 5 animals at 1000 mg/kg bw/day
Results and discussion
Results of examinations
- Details on results:
- Clinical observations:
Mortality Data:
There were no deaths during the study that could be
considered attributable to test material toxicity. One
female treated with 400 mg/kg/day was found dead on Day 21.
Clinical Observations:
No clinically observable signs of toxicity were detected in
test or control animals throughout the study period.
Behavioural Assessment:
No treatment-related changes were detected.
Functional Performance Tests:
No treatment-related changes were detected.
Sensory Reactivity Assessments:
No treatment-related changes were detected.
Bodyweight:
No adverse effect on bodyweight development was detected.
Food Consumption:
No adverse effect on dietary intake or food efficiency was
detected.
Water Consumption:
No intergroup differences were detected.
Laboratory findings:
Haematology:
No treatment-related effects were detected.
Blood Chemistry:
No treatment-related effects were detected.
Effects in organs:
Necropsy:
No treatment-related macroscopic abnormalities were detected
at terminal kill. The interim death showed normal post
mortem changes.
Organ Weights:
No treatment-related effects were detected.
Histopathology:
No treatment-related microscopic abnormalities were
observed.
Effect levels
open allclose all
- Dose descriptor:
- NOAEL
- Effect level:
- 1 000 mg/kg bw/day (nominal)
- Basis for effect level:
- other: original NCD unit is mg/kg/day.
- Dose descriptor:
- NOEL
- Effect level:
- 1 000 mg/kg bw/day (nominal)
- Basis for effect level:
- other: original NCD unit is mg/kg/day.
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- Classified as: Not classified
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
